Corundum Group, Inc. Pfizer Inc Transaction History
Corundum Group, Inc.
- $266 Million
- Q4 2024
A detailed history of Corundum Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Corundum Group, Inc. holds 13,802 shares of PFE stock, worth $349,742. This represents 0.14% of its overall portfolio holdings.
Number of Shares
13,802
Previous 42,741
67.71%
Holding current value
$349,742
Previous $1.24 Million
70.39%
% of portfolio
0.14%
Previous 0.57%
Shares
33 transactions
Others Institutions Holding PFE
# of Institutions
3,378Shares Held
3.56BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.8 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.36 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.94 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA121MShares$3.06 Billion0.25% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $142B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...